These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 31501038

  • 1. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J, Shen X, Han C, Mei C, Zhou Y, Wang H, Kong Y, Jiang Y, Fang Q, Cai X.
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T, Hanumanthu R, Khandelwal P.
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [Abstract] [Full Text] [Related]

  • 3. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Nov; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 4. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, Nolte CH.
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [Abstract] [Full Text] [Related]

  • 5. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
    AbdelRazek MA, Mowla A, Hojnacki D, Zimmer W, Elsadek R, Abdelhamid N, Elsadek L, Farooq S, Kamal H, Crumlish A, Shirani P, Ching M, Sawyer R.
    Cerebrovasc Dis; 2015 Nov; 40(5-6):201-4. PubMed ID: 26402147
    [Abstract] [Full Text] [Related]

  • 6. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X, Wang D, Wang F, Norton C, Liu X, Selim M.
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [Abstract] [Full Text] [Related]

  • 7. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Sep; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 8. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD.
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [Abstract] [Full Text] [Related]

  • 9. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).
    Marsh EB, Gottesman RF, Hillis AE, Urrutia VC, Llinas RH.
    Medicine (Baltimore); 2013 Nov; 92(6):317-323. PubMed ID: 24145699
    [Abstract] [Full Text] [Related]

  • 10. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC.
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [Abstract] [Full Text] [Related]

  • 11. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Yang Y, Liu B, Wu L, Guan X, Luo Y, Jiang C, Gupta S, Huang Z, Everett G.
    Cerebrovasc Dis; 2019 May; 48(3-6):157-164. PubMed ID: 31694030
    [Abstract] [Full Text] [Related]

  • 12. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 13. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Mowla A, Kamal H, Lail NS, Vaughn C, Shirani P, Mehla S, Rajabzadeh-Oghaz H, Deline C, Ching M, Crumlish A, Sawyer RN.
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515
    [Abstract] [Full Text] [Related]

  • 14. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
    Pan Y, Chen Q, Liao X, Zhao X, Wang C, Liu G, Liu L, Wang C, Wang D, Wang Y, Wang Y, TIMS-China Investigators.
    Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494
    [Abstract] [Full Text] [Related]

  • 15. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY, Lin HJ, Sung SF, Yang YH, Lai EC, Hsieh HC, Chen CH.
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [Abstract] [Full Text] [Related]

  • 16. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ, Wang X, Olavarria VV, Lavados PM, Rodriguez JA, Kim JS, Lee TH, Lindley RI, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Woodward M, Chalmers J, Anderson CS, Robinson TG, ENCHANTED Investigators.
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [Abstract] [Full Text] [Related]

  • 17. Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke.
    Liu M, Pan Y, Zhou L, Wang Y.
    PLoS One; 2017 Sep; 12(9):e0184646. PubMed ID: 28922363
    [Abstract] [Full Text] [Related]

  • 18. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
    [Abstract] [Full Text] [Related]

  • 19. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW, Zhang XJ, Cheng LS, Li GY, Zhang LJ, Ji KX, Zhao Q, Bai Y.
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [Abstract] [Full Text] [Related]

  • 20. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S, Japan Alteplase Clinical Trial Group.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.